For the first time since the pandemic started, we are pleased to announce that the 4th Annual European HealthTech CEO Forum(EHTF) will take place In-Person on the 28th February 2023 back at the Hilton Zurich Airport Hotel. The event will be part of the Sachs Spring Life Sciences Week, which will also incorporate the 16th Annual European Life Sciences CEO Forum.
The 4th EHTF is a unique annual gathering of industry leaders from Europe, Asia and the USA. The main programme will feature more than 5 hours of high-level speeches and panel discussions focusing on investment & partnership in MedTech and Digital Health. In addition, there will be a global company showcase of 25+ presentations by established public, private, emerging and seed companies, offering innovative solutions and are seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated presenting tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We expect around 250+ delegates from 20 countries to join us in Zurich for the networking and business opportunities. These include Digital Health, MedTech/Device companies, banks, investors and advisors with part of the audience participating virtually.
The In-Person meetings will be taking place on the 28th of February, while virtual meetings will take place on the 8th - 10th of March. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as option to present slides using a screen share function and we will have a dedicated room for in-person meetings. We expect 2000+ meetings completed during SSLSW. The conference will be held in the Central European Time Zone. The programme will consist of:
Tuesday, 28th of February
European Medical Innovation: Meeting the Global Challenge Panel
Complimentary passes are provided for qualified institutional (buy/sell-side), private equity and venture investors. The number of passes is limited, and priority is given to regular participants, however the organiser has the discretion to reject registrations. Other participants may consider purchasing access, which includes in-person or virtual participation, with different options to showcase your company.
The Online Meeting System will open on the 14th of February for uploading profiles and sending meeting invites. The in-person meetings will be taking place on the 28th of February, while virtual meetings will take place on the 8th - 10th of March . For the virtual meetings, the system will allow you to have a secure audio/video call, as well as an option to present slides using a screen share function and we will have a dedicated room for in-person meetings
Presentations are a popular and useful way to gain additional exposure with potential investors and pharma partners, which make up over half the audience. We are pleased to announce that once again we will have 20-minute and 10-minute presentations taking place in-person at the dedicated presenting tracks. Here you will be able to showcase your company in front of investors attending the physical event. The recording will be added to your company’s profile later, which will be available on demand for registered participants until the event portal closes.
For those who are not able to present in-person, but are still interested to showcase their company, there is an option to purchase either a 20 or 10 minute presentation, which will be pre-recorded in advance and available to all registered attendees on the event’s portal. Start-up companies may also purchase a 5-minute pre-recorded showcase instead.
The Sachs Team can assist with the pre-recording of the presentation, or you can upload a video you already have. Interested viewers will be able to message or request a meeting with you using the Online Meeting System.
Showcases in 2022 Included:
Make connections, engage in conversation, and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at Sachs Spring Life Sciences Week is an effective way to gain leads, introduce new products and services, expand sales, and build relationships.
If attending the physical event, we have a limited number (limited to 3 companies) of table-top exhibitions available at the venue, which would be located at the main foyer, next to the plenary room, where we have the highest attendee traffic.
For those who are not able to join the event or exhibit in-person, you could choose virtual exhibition package, which includes a dedicated virtual page, where we can: upload your branded company’s profile and list ways to reach you; share video or images about services you provide and have files ready for download, if you wish to share any additional information with potential clients.
If interested in learning more about exhibition options, please fill in the registration form.
There are a limited number of sponsorship opportunities for the forum, which includes speaking, advertising, and branding options. Sponsors typically include investment banks and funds, large pharma, technology companies and service providers, including Stock Exchanges, IR companies, CROs, international lawyers and consulting companies. Tailored packages are available upon request. You can view the latest event’s sponsors here.
To learn more about presenting, exhibition or sponsorship opportunities, please fill in registration form or contact us at SachsTeam@SachsForum.com or by phone + 44 (0)203 463 4890.
Participating Pharmas in 2022:
Investors & Analysts in 2022: 3B Future Health Ventures Abingworth LLP AdBio Partners Additio Investment Group Aescuvest International Alon MedTech Ventures Alpha Blue Ocean Ltd. Amadeus Capital Partners aMoon Fund Apeiron Investments Apollo Health Ventures Aqua Partners LLC ARCH Venture Partners Asabys Partners Asklepios Advisors ATGN Consulting BCG Digital Ventures Bergmann zur Hausen & Cie. GmbH BERNINA BioInvest Ltd. BIMA Capital, LLC Bio Medi Gene Ventures BIOSTART Consulting GmbH BioValley Basel & Suterscience, LLC BioVeda China Fund (BVCF) bmp Ventures AG Bootstrap Europe SCSP Bradley Woods & Co. Ltd Brightlands Venture Partners Brookline Capital Markets BROTHERS & Partners Europe Capricorn Partners Catalytic Impact Foundation, Inc. Cello Health BioConsulting Clave Mayor S.G.E.I.C., S.A. coparion GmbH & Co. KG Cukierman & Co. Life Sciences Debiopharm Innovation Fund SA Deutsche Bank Digital Networks PLC E.Gutzwiller & Cie, Banquiers Eight Roads Ventures ESC Advisors Ferghana Partners LLP Fraser Finance LLP FutuRx Ltd. GCF Family Office GEM Generation Fund Life Sciences Fund I Gilde Healthcare Partners Gimv NV Global Founders Capital Global Health Investment Corporation GLSV GmbH iL | MicroCures Inc | Neurevo GmbH Hadean Ventures High-Tech Gründerfonds Management GmbH IAG - Italian Angels for Growth IAG, Image Analysis Group IBB Beteiligungsgesellschaft GmbH ICF Consult Switzerland Ignite Capital Partners, Inc. Illumina Ventures Indaco Venture Partners SGR SpA Independent R.B. Independent R.M. Industrifonden INKEF Capital BV Inveready Asset Management IPF Partners